EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Driving adoption of new technologies in biopharmaceutical manufacturing

Gene Schaefer iD, John Balchunas, Timothy Charlebois, John Erickson iD, Roger Hart, Sandeep B Kedia iD, Kelvin H Lee iD

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Gene Schaefer und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Drug Industry, Biological Products. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Standards and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenge of introducing new technologies into established industries is not a problem unique to the biopharmaceutical industry. However, it may be critical to the long‐term competitiveness of individual manufacturers and, more importantly, the ability to deliver therapies to patients. This is especially true for new treatment modalities including cell and gene therapies. We review several barriers to technology adoption which have been identified in various public forums including business, regulatory, technology, and people‐driven concerns. We also summarize suitable enablers addressing one or more of these barriers along with suggestions for developing synergies or connections between innovation in product discovery and manufacturing or across the supplier, discovery, manufacturing, and regulatory arms of the holistic innovation engine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug IndustryBiological ProductsHumansTechnology

Stichwörter der Autor:innen

advanced manufacturingbioprocessinnovationintensified continuous bioprocesstechnology adoption

Substanzen

Biological Products

Autor:innen und Institutionen

  • National Institute for Innovation in Manufacturing Biopharmaceuticals, Newark, Delaware, USA.

ORCID-Profile: Gene Schaefer, John Erickson, Sandeep B Kedia, Kelvin H Lee

Förderung

  • National Institute of Standards and Technology

Zitieren

APA

Schaefer, G., Balchunas, J., Charlebois, T., Erickson, J., Hart, R., Kedia, S. B., & Lee, K. H. (2023). Driving adoption of new technologies in biopharmaceutical manufacturing. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28395

Vancouver

Schaefer G, Balchunas J, Charlebois T, Erickson J, Hart R, Kedia SB, et al. Driving adoption of new technologies in biopharmaceutical manufacturing. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28395

BibTeX
@article{Schaefer2023,
  author = {Schaefer, Gene and Balchunas, John and Charlebois, Timothy and Erickson, John and Hart, Roger and Kedia, Sandeep B and Lee, Kelvin H},
  title = {Driving adoption of new technologies in biopharmaceutical manufacturing},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28395}
}
Kostenlos starten →